Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Emergence from General Anesthesia
NCT02429076Phase 2Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of methylphenidate in general anesthesia, sponsored by Massachusetts General Hospital. Planned start Jun 2017; status: withdrawn.
02
Drugs
methylphenidate
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT02429076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429076.